The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump.

The Centers for Medicare and Medicaid Services (CMS) had until Feb. 1 to release the list, but officials said the agency had routinely been ahead of schedule throughout the process.

Coupled with the first 10 drugs that have already been negotiated for by Medicare, the newest selection of drugs represent a third of all Medicare Part D spending. Some of the manufacturers that will have to negotiate this year were also included in last year's talks.

“Today, I’m proud to announce that my Administration has selected the next 15 drugs for Medicare drug price negotiation. The drugs treat conditions such as........

© The Hill